SAT0182 Sirukumab leads to significant and clinically meaningful improvements in health-related quality of life that meet or exceed normative values in patients with rheumatoid arthritis refractory to tnf inhibitors in post hoc analyses of a phase 3 trial
V Strand
◽
R Ganguly
◽
N Li
◽
K McQuarrie
2015 ◽
Vol 74
(Suppl 2)
◽
pp. 440.1-440
V. Strand
◽
M. Kosinski
◽
G. Joseph
◽
C. Chen
◽
H. Van Hoogstraten
◽
...
M Dougados
◽
B Zhu
◽
AC Tang
◽
A Quebe
◽
I Stoykov
◽
...
2020 ◽
Vol Volume 13
◽
pp. 181-191
Hiroyuki Enomoto
◽
Shinji Fujikoshi
◽
Kei Ogawa
◽
Toshinaga Tsuji
◽
Sakae Tanaka
2016 ◽
Vol 27
◽
pp. vi245
J.S. de Bono
◽
A.-C. Hardy-Bessard
◽
C.S. Kim
◽
L. Géczi
◽
D. Ford
◽
...
V Strand
◽
K McQuarrie
◽
N Li
◽
R Ganguly
2021 ◽
Vol 77
(18)
◽
pp. 3304
Martha Grogan
◽
Mathew S. Maurer
◽
Ronald Witteles
◽
Divaya Bhutani
◽
Raymond L. Comenzo
◽
...
P. L. Zinzani
◽
M. Raut
◽
T. Saretsky
◽
R. Ramchandren
◽
A. Santoro
◽
...
2011 ◽
Vol 32
(6)
◽
pp. 1521-1525
◽
Filiz Eser
◽
Yeşim Garip
◽
Hatice Bodur
2014 ◽
Vol 73
(Suppl 2)
◽
pp. 537.3-537
K. Kotsis
◽
T. Hyphantis
◽
N. Tsifetaki
◽
P.V. Voulgari
◽
A.A. Drosos
Close
Export Citation Format
Close
Share Document
Close